What are the benefits and safe usage guidelines of L-threonine (an amino acid) supplementation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benefits and Safe Usage Guidelines of L-Threonine Supplementation

L-threonine supplementation is generally safe for healthy adults at doses up to 12 g/day, with potential benefits for intestinal health, though evidence for other clinical applications remains limited. 1

What is L-Threonine?

  • L-threonine is an essential amino acid that cannot be synthesized by humans and must be provided through diet or supplementation 2
  • It serves as an important component in protein synthesis and has specific roles in intestinal health 3
  • The recommended daily allowance (RDA) for protein, which includes threonine, is 0.8 g/kg/day for adults 2

Established Benefits of L-Threonine

  • Intestinal Health: L-threonine is an integral component of gut function and has been shown to increase mucin 2 gene expression, which is important for maintaining intestinal barrier function 3
  • Protein Synthesis: As an essential amino acid, L-threonine is required for normal protein synthesis throughout the body 2
  • Immune Function: Research suggests threonine might function as a nutrient immunomodulator in maintaining intestinal barrier function by increasing IgA antibody concentrations in the intestinal mucosa 3

Potential Therapeutic Applications

  • Spasticity Management: Some research has shown L-threonine supplementation (4.5-6.0 g/day) may decrease motor impairment and spasticity in patients with familial spastic paraparesis, though the clinical benefits were modest 4
  • Nutritional Supplementation: L-threonine can be used to improve the quality of vegetable proteins that are deficient in this essential amino acid 5

Safety and Dosage Guidelines

  • A randomized, double-blind controlled trial established a no-observed-adverse-effect-level (NOAEL) of 12 g/day for L-threonine in healthy adult males 1
  • Supplementation at doses of 3-12 g/day for 4 weeks showed minimal effects on biochemical parameters, with only minor increases in plasma aspartate amino transferase and creatine kinase at 9 g/day (but not at 12 g/day) 1
  • Adverse events reported during supplementation were mild to moderate and resolved during the supplementation period despite continued intake 1

Special Considerations

  • Parenteral Nutrition: In clinical settings where parenteral nutrition is required, specific amino acid requirements including threonine have been established:

    • For infants, threonine requirements are approximately 38 mg/kg/day 2
    • For adults, threonine is included as part of standard amino acid formulations 6
  • Stability Considerations: When formulated in supplements or medical foods, the stability of threonine can be affected by pH levels and interactions with other ingredients 7

Common Pitfalls to Avoid

  • Assuming all amino acids have similar safety profiles - each has unique metabolic pathways and potential side effects 8
  • Exceeding recommended doses without medical supervision - while safe at tested levels, very high doses have not been extensively studied 1
  • Using acetylated derivatives of threonine in foods that require heat processing, as this may affect bioavailability 5

Conclusion

While L-threonine supplementation appears safe at doses up to 12 g/day in healthy adults, the clinical evidence supporting specific therapeutic benefits beyond basic nutritional requirements remains limited. The strongest evidence points to potential benefits for intestinal health and barrier function, with preliminary evidence for applications in spasticity management.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

L-threonine in the treatment of spasticity.

Clinical neuropharmacology, 1991

Research

Bioavailability of acetylated derivatives of methionine, threonine, and lysine.

Advances in experimental medicine and biology, 1978

Guideline

Aminoven Dosing in Neonates

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Peptide Serum Compatibility and Stability

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Glutamine Supplementation in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.